In transition and tumult, Seagen names former Novartis oncology chief Epstein as new CEO

Nearly seven months after Seagen was rocked by the domestic abuse arrest of founder, chairman and CEO Clay Siegall and his subsequent resignation, the powerhouse Seattle biotech has found its new leader.